• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Prosonix

edit

Prosonix is world leader in the commercialization of proprietary pharmaceutical ultrasonic particle engineering technologies and added value ultrasonic process chemistry solutions. A core expertise is the development of new ‘molecule to particle’ methods for manufacture of inhaled medicines.

Milestones

edit

• 
  Prosonix added Andy Bush as Chief Operating Officer / Chief Financial Officer.
  Posted 5/24/12 at 5:31am
• 
  Prosonix added David Hipkiss as Chief Executive Officer.
  Posted 5/24/12 at 5:31am
• 
  Prosonix received (£17.1M) in Series B funding. (5/24/12)
  Posted 5/24/12 at 5:33am via finsmes.com
• 
  Prosonix received $18.2M (£11.4M) in Series B funding. (7/6/11)
  Posted 7/7/11 at 7:28pm via co.uk

Videos

Screenshots

edit

Above: Prosonix
Uploaded: 7/8/11

Sources

1. Prosonix Raises £11.4 Million In Series B Financing (growthbusiness.co.uk) [edit]
2. Prosonix Raised £17.1M in Series B Equity Financing (finsmes.com) [edit]